Abstract
This editorial refers to ‘Proteinase-activated receptor 1 antagonism ameliorates experimental pulmonary hypertension’, by Y. Kuwabara et al., pp. 1357–1368
| Original language | English |
|---|---|
| Pages (from-to) | 1260-1261 |
| Number of pages | 2 |
| Journal | Cardiovascular Research |
| Volume | 115 |
| Issue number | 8 |
| Early online date | 23 Mar 2019 |
| DOIs | |
| Publication status | Published - 1 Jul 2019 |
Bibliographical note
Published on behalf of the European Society of Cardiology. All rights reserved. Copyright: The Author(s) 2019Research programs
- EMC COEUR-09
Fingerprint
Dive into the research topics of 'Protease-activated receptor 1 as potential therapeutic target in pulmonary arterial hypertension'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver